These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 310334)

  • 1. Immunological monitoring during chemotherapy for advanced Hodgkin's disease.
    Alexopoulos CG; Wiltshaw E
    Cancer; 1978 Dec; 42(6):2631-40. PubMed ID: 310334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission.
    Gobbi M; Fiacchini M; Tomasini I; Ruggero D; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):144-51. PubMed ID: 326273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of maintenance MOPP/COPP treatment on the number and function of peripheral T- and B-lymphocytes in Hodgkin's disease during remission].
    Płuzańska A; Kałuzna W
    Pol Arch Med Wewn; 1981 Jun; 65(6):475-81. PubMed ID: 6973752
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].
    Nagel GA; Pietra CD; Hartmann D; Rosenthal M; Albrecht R; Obrist R; Obrecht P
    Schweiz Med Wochenschr; 1979 Jan; 109(2):45-51. PubMed ID: 311514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosette formation in Hodgkin's disease.
    Swain A; Trounce JR
    Oncology; 1974; 30(6):449-57. PubMed ID: 4549695
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of host defence against infection during chemotherapy of Hodgkin's disease.
    Addison I; Babbage J; Gandossini M; Souhami R
    Cancer Chemother Pharmacol; 1978; 1(3):129-33. PubMed ID: 312166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 10. The lymphocyte response in Hodgkin's disease.
    Braeman J; Evans IH; Deeley TJ
    Clin Radiol; 1975 Jul; 26(3):305-9. PubMed ID: 1081440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T- and B-lymphocyte changes in lymphogranulomatosis].
    Il'in NV; Vinokurova NA; Gershanovich ML; Letskiĭ VB
    Vopr Onkol; 1979; 25(6):19-22. PubMed ID: 380155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of B and T lymphocytes in the peripheral blood of patients with Hodgkin's disease.
    Many A; Biniaminov M; Rosenthal E; Aghai E; Ramot B
    Acta Haematol; 1976; 56(1):1-6. PubMed ID: 822670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T and B blocking factors in Hodgkin's disease.
    Bentwich R; Cohen R; Brautbar C
    Adv Exp Med Biol; 1976; 66():685-90. PubMed ID: 1083664
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.